{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:59:58Z","timestamp":1793275198276,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T00:00:00Z","timestamp":1479513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T00:00:00Z","timestamp":1479513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MT-14037"],"award-info":[{"award-number":["MT-14037"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-81112"],"award-info":[{"award-number":["MOP-81112"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG17917"],"award-info":[{"award-number":["R01AG17917"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG42210"],"award-info":[{"award-number":["R01AG42210"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00401-016-1647-9","type":"journal-article","created":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T13:08:10Z","timestamp":1479560890000},"page":"395-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"133","author":[{"given":"Alfredo","family":"Ramos-Miguel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen E.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair M.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue E.","family":"Leurgans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Honer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,19]]},"reference":[{"key":"1647_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","volume":"74","author":"A Bakker","year":"2012","unstructured":"Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, Yassa MA, Bassett SS, Shelton AL, Gallagher M (2012) Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron 74:467\u2013474. doi: 10.1016\/j.neuron.2012.03.023","journal-title":"Neuron"},{"key":"1647_CR2","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/npp.2009.228","volume":"35","author":"VE Barakauskas","year":"2010","unstructured":"Barakauskas VE, Beasley CL, Barr AM, Ypsilanti AR, Li H-Y, Thornton AE, Wong H, Rosokilja G, Mann JJ, Mancevski B, Jakovski Z, Davceva N, Ilievski B, Dwork AJ, Falkai P, Honer WG (2010) A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia. Neuropsychopharmacol 35:1226\u20131238. doi: 10.1038\/npp.2009.228","journal-title":"Neuropsychopharmacol"},{"key":"1647_CR3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/archgenpsychiatry.2010.107","volume":"67","author":"M Begemann","year":"2010","unstructured":"Begemann M, Grube S, Papiol S, Malzahn D, Krampe H, Ribbe K, Friedrichs H, Radyushkin KA, El-Kordi A, Benseler F, Hannke K, Sperling S, Schwerdtfeger D, Thanh\u00e4user I, Gerchen MF, Ghorbani M, Gutwinski S, Hilmes C, Leppert R, Ronnenberg A, Sowislo J, Stawicki S, St\u00f6dtke M, Szuszies C, Reim K, Riggert J, Eckstein F, Falkai P, Bickeb\u00f6ller H, Nave K-A, Brose N, Ehrenreich H (2010) Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch Gen Psychiatry 67:879\u2013888. doi: 10.1001\/archgenpsychiatry.2010.107","journal-title":"Arch Gen Psychiatry"},{"key":"1647_CR4","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","volume":"66","author":"DA Bennett","year":"2006","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurol 66:1837\u20131844. doi: 10.1212\/01.wnl.0000219668.47116.e6","journal-title":"Neurol"},{"key":"1647_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000087446","volume":"25","author":"DA Bennett","year":"2005","unstructured":"Bennett DA, Schneider JA, Buchman AS, Mendes de Leon C, Bienias JL, Wilson RS (2005) The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiol 25:163\u2013175. doi: 10.1159\/000087446","journal-title":"Neuroepidemiol"},{"issue":"Suppl 1","key":"1647_CR6","doi-asserted-by":"publisher","first-page":"S397","DOI":"10.3233\/JAD-2012-129007","volume":"33","author":"DA Bennett","year":"2013","unstructured":"Bennett DA, Wilson RS, Arvanitakis Z, Boyle PA, de Toledo-Morrell L, Schneider JA (2013) Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis 33(Suppl 1):S397\u2013S403. doi: 10.3233\/JAD-2012-129007","journal-title":"J Alzheimers Dis"},{"key":"1647_CR7","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1093\/brain\/awq258","volume":"133","author":"K Bossers","year":"2010","unstructured":"Bossers K, Wirz KTS, Meerhoff GF, Essing AHW, van Dongen JW, Houba P, Kruse CG, Verhaagen J, Swaab DF (2010) Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer\u2019s disease. Brain 133:3699\u20133723. doi: 10.1093\/brain\/awq258","journal-title":"Brain"},{"key":"1647_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1212\/01.wnl.0000228244.10416.20","volume":"67","author":"PA Boyle","year":"2006","unstructured":"Boyle PA, Wilson RS, Aggarwal NT, Tang Y, Bennett DA (2006) Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurol 67:441\u2013445. doi: 10.1212\/01.wnl.0000228244.10416.20","journal-title":"Neurol"},{"key":"1647_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ana.23964","volume":"74","author":"PA Boyle","year":"2013","unstructured":"Boyle PA, Wilson RS, Yu L, Barr AM, Honer WG, Schneider JA, Bennett DA (2013) Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol 74:478\u2013489. doi: 10.1002\/ana.23964","journal-title":"Ann Neurol"},{"key":"1647_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"1647_CR11","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1093\/brain\/awv236","volume":"138","author":"H Braak","year":"2015","unstructured":"Braak H, Del Tredici K (2015) The preclinical phase of the pathological process underlying sporadic Alzheimer\u2019s disease. Brain 138:2814\u20132833. doi: 10.1093\/brain\/awv236","journal-title":"Brain"},{"key":"1647_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0006-8993(91)90697-T","volume":"539","author":"JP Brion","year":"1991","unstructured":"Brion JP, Couck AM, Bruce M, Anderton B, Flament-Durand J (1991) Synaptophysin and chromogranin A immunoreactivities in senile plaques of Alzheimer\u2019s disease. Brain Res 539:143\u2013150","journal-title":"Brain Res"},{"key":"1647_CR13","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1126\/science.1162844","volume":"321","author":"MA Busche","year":"2008","unstructured":"Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold K-H, Haass C, Staufenbiel M, Konnerth A, Garaschuk O (2008) Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease. Science 321:1686\u20131689. doi: 10.1126\/science.1162844","journal-title":"Science"},{"key":"1647_CR14","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1529\/biophysj.103.038422","volume":"86","author":"SV Costes","year":"2004","unstructured":"Costes SV, Daelemans D, Cho EH, Dobbin Z, Pavlakis G, Lockett S (2004) Automatic and quantitative measurement of protein\u2013protein colocalization in live cells. Biophys J 86:3993\u20134003. doi: 10.1529\/biophysj.103.038422","journal-title":"Biophys J"},{"key":"1647_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL, Wisniewski T, Woltjer RL, Yamada M, Nelson PT (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755\u2013766. doi: 10.1007\/s00401-014-1349-0","journal-title":"Acta Neuropathol"},{"key":"1647_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","volume":"17","author":"E Cumbo","year":"2010","unstructured":"Cumbo E, Ligori LD (2010) Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer\u2019s disease. Epilepsy Behav 17:461\u2013466. doi: 10.1016\/j.yebeh.2010.01.015","journal-title":"Epilepsy Behav"},{"key":"1647_CR17","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1111\/j.1460-9568.1996.tb00727.x","volume":"8","author":"S Davis","year":"1996","unstructured":"Davis S, Rodger J, Hicks A, Mallet J, Laroche S (1996) Brain structure and task-specific increase in expression of the gene encoding syntaxin 1B during learning in the rat: a potential molecular marker for learning-induced synaptic plasticity in neural networks. Eur J Neurosci 8:2068\u20132074","journal-title":"Eur J Neurosci"},{"key":"1647_CR18","first-page":"79","volume":"96","author":"EG Gray","year":"1962","unstructured":"Gray EG, Whittaker VP (1962) The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat 96:79\u201388","journal-title":"J Anat"},{"key":"1647_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00406-014-0550-4","volume":"265","author":"J Hass","year":"2014","unstructured":"Hass J, Walton E, Kirsten H, Turner J, Wolthusen R, Roessner V, Sponheim SR, Holt D, Gollub R, Calhoun VD, Ehrlich S (2014) Complexin2 modulates working memory-related neural activity in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 265:137\u2013145. doi: 10.1007\/s00406-014-0550-4","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1647_CR20","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1038\/tp.2012.38","volume":"2","author":"WG Honer","year":"2012","unstructured":"Honer WG, Barr AM, Sawada K, Thornton AE, Morris MC, Leurgans SE, Schneider JA, Bennett DA (2012) Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl Psychiatry 2:e114. doi: 10.1038\/tp.2012.38","journal-title":"Transl Psychiatry"},{"key":"1647_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0006-8993(93)90848-H","volume":"609","author":"WG Honer","year":"1993","unstructured":"Honer WG, Hu L, Davies P (1993) Human synaptic proteins with a heterogeneous distribution in cerebellum and visual cortex. Brain Res 609:9\u201320","journal-title":"Brain Res"},{"key":"1647_CR22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","volume":"5","author":"R Ihaka","year":"1996","unstructured":"Ihaka R, Gentleman R (1996) R: a language for data analysis and graphics. J Comput Graph Stat 5:299\u2013314","journal-title":"J Comput Graph Stat"},{"key":"1647_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00401-006-0068-6","volume":"112","author":"VE Koliatsos","year":"2006","unstructured":"Koliatsos VE, Kecojevic A, Troncoso JC, Gastard MC, Bennett DA, Schneider JA (2006) Early involvement of small inhibitory cortical interneurons in Alzheimer\u2019s disease. Acta Neuropathol 112:147\u2013162. doi: 10.1007\/s00401-006-0068-6","journal-title":"Acta Neuropathol"},{"key":"1647_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00401-015-1507-z","volume":"131","author":"J Lewis","year":"2015","unstructured":"Lewis J, Dickson DW (2015) Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:27\u201348. doi: 10.1007\/s00401-015-1507-z","journal-title":"Acta Neuropathol"},{"key":"1647_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnagi.2016.00031","volume":"8","author":"Y Li","year":"2016","unstructured":"Li Y, Sun H, Chen Z, Xu H, Bu G, Zheng H (2016) Implications of GABAergic neurotransmission in Alzheimer\u2019s disease. Front Aging Neurosci 8:31. doi: 10.3389\/fnagi.2016.00031","journal-title":"Front Aging Neurosci"},{"key":"1647_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13024-016-0103-6","volume":"11","author":"J Luo","year":"2016","unstructured":"Luo J, Lee SH, VandeVrede L, Qin Z, Ben Aissa M, Larson J, Teich AF, Arancio O, D\u2019Souza Y, Elharram A, Koster K, Tai LM, LaDu MJ, Bennett BM, Thatcher GRJ (2016) A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer\u2019s disease. Mol Neurodegener 11:35. doi: 10.1186\/s13024-016-0103-6","journal-title":"Mol Neurodegener"},{"key":"1647_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12868-015-0208-9","volume":"16","author":"J Luo","year":"2015","unstructured":"Luo J, Lee SH, VandeVrede L, Qin Z, Piyankarage S, Tavassoli E, Asghodom RT, Ben Aissa M, F\u00e0 M, Arancio O, Yue L, Pepperberg DR, Thatcher GRJ (2015) Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia. BMC Neurosci 16:67. doi: 10.1186\/s12868-015-0208-9","journal-title":"BMC Neurosci"},{"key":"1647_CR28","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci 101:9861\u20139866. doi: 10.1073\/pnas.0308208101","journal-title":"Proc Natl Acad Sci"},{"key":"1647_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF00296182","volume":"87","author":"E Masliah","year":"1994","unstructured":"Masliah E, Honer WG, Mallory M, Voigt M, Kushner P, Hansen L, Terry R (1994) Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer\u2019s disease hippocampus. Acta Neuropathol 87:135\u2013142","journal-title":"Acta Neuropathol"},{"key":"1647_CR30","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/j.1528-1167.2008.01687.x","volume":"49","author":"EA Matveeva","year":"2008","unstructured":"Matveeva EA, Vanaman TC, Whiteheart SW, Slevin JT (2008) Levetiracetam prevents kindling-induced asymmetric accumulation of hippocampal 7S SNARE complexes. Epilepsia 49:1749\u20131758. doi: 10.1111\/j.1528-1167.2008.01687.x","journal-title":"Epilepsia"},{"key":"1647_CR31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/jnen\/60.10.929","volume":"60","author":"SL Minger","year":"2001","unstructured":"Minger SL, Honer WG, Esiri MM, McDonald B, Keene J, Nicoll JA, Carter J, Hope T, Francis PT (2001) Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J Neuropathol Exp Neurol 60:929\u2013936","journal-title":"J Neuropathol Exp Neurol"},{"key":"1647_CR32","first-page":"132","volume":"117","author":"SS Mirra","year":"1993","unstructured":"Mirra SS, Hart MN, Terry RD (1993) Making the diagnosis of Alzheimer\u2019s disease. A primer for practicing pathologists. Arch Pathol Lab Med 117:132\u2013144","journal-title":"Arch Pathol Lab Med"},{"issue":"4S","key":"1647_CR33","first-page":"S1","volume":"18","author":"National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer\u201ds Disease","year":"1997","unstructured":"National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer\u201ds Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer\u201cs disease. Neurobiol Aging 18(4S):S1\u2013S2","journal-title":"Neurobiol Aging"},{"key":"1647_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(00)03589-3","volume":"357","author":"Neuropathology Group, Medical Research Council Cognitive Function and Aging Study","year":"2001","unstructured":"Neuropathology Group, Medical Research Council Cognitive Function and Aging Study (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357:169\u2013175","journal-title":"Lancet"},{"key":"1647_CR35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/archneurol.2009.15","volume":"66","author":"JJ Palop","year":"2009","unstructured":"Palop JJ, Mucke L (2009) Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol 66:435\u2013440. doi: 10.1001\/archneurol.2009.15","journal-title":"Arch Neurol"},{"key":"1647_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13024-015-0061-4","volume":"10","author":"A Ramos-Miguel","year":"2015","unstructured":"Ramos-Miguel A, Hercher C, Beasley CL, Barr AM, Bayer TA, Falkai P, Leurgans SE, Schneider JA, Bennett DA, Honer WG (2015) Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample. Mol Neurodegener 10:65. doi: 10.1186\/s13024-015-0061-4","journal-title":"Mol Neurodegener"},{"key":"1647_CR37","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.neuroscience.2015.06.022","volume":"301","author":"A Ramos-Miguel","year":"2015","unstructured":"Ramos-Miguel A, Honer WG, Boyda HN, Sawada K, Beasley CL, Procyshyn RM, Barr AM (2015) Exercise prevents downregulation of hippocampal presynaptic proteins following olanzapine-elicited metabolic dysregulation in rats: Distinct roles of inhibitory and excitatory terminals. Neurosci 301:298\u2013311. doi: 10.1016\/j.neuroscience.2015.06.022","journal-title":"Neurosci"},{"key":"1647_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ana.10161","volume":"51","author":"KP Riley","year":"2002","unstructured":"Riley KP, Snowdon DA, Markesbery WR (2002) Alzheimer\u2019s neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol 51:567\u2013577. doi: 10.1002\/ana.10161","journal-title":"Ann Neurol"},{"key":"1647_CR39","doi-asserted-by":"publisher","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","volume":"109","author":"PE Sanchez","year":"2012","unstructured":"Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, Devidze N, Ho K, Yu G-Q, Palop JJ, Mucke L (2012) Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model. Proc Natl Acad Sci 109:E2895\u2013E2903. doi: 10.1073\/pnas.1121081109","journal-title":"Proc Natl Acad Sci"},{"key":"1647_CR40","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3389\/fncel.2015.00318","volume":"9","author":"CA Saura","year":"2015","unstructured":"Saura CA, Parra-Damas A, Enriquez-Barreto L (2015) Gene expression parallels synaptic excitability and plasticity changes in Alzheimer\u2019s disease. Front Cell Neurosci 9:1567. doi: 10.1038\/npp.2011.107","journal-title":"Front Cell Neurosci"},{"key":"1647_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1001\/archpsyc.62.3.263","volume":"62","author":"K Sawada","year":"2005","unstructured":"Sawada K, Barr AM, Nakamura M, Arima K, Young CE, Dwork AJ, Falkai P, Phillips AG, Honer WG (2005) Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry 62:263\u2013272. doi: 10.1001\/archpsyc.62.3.263","journal-title":"Arch Gen Psychiatry"},{"key":"1647_CR42","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/sj.mp.4000978","volume":"7","author":"K Sawada","year":"2002","unstructured":"Sawada K, Young CE, Barr AM, Longworth K, Takahashi S, Arango V, Mann JJ, Dwork AJ, Falkai P, Phillips AG, Honer WG (2002) Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol Psychiatry 7:484\u2013492. doi: 10.1038\/sj.mp.4000978","journal-title":"Mol Psychiatry"},{"key":"1647_CR43","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","volume":"69","author":"JA Schneider","year":"2007","unstructured":"Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69:2197\u20132204. doi: 10.1212\/01.wnl.0000271090.28148.24","journal-title":"Neurology"},{"key":"1647_CR44","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/jnen\/nlw026","volume":"75","author":"A Serrano-Pozo","year":"2016","unstructured":"Serrano-Pozo A, Qian J, Muzikansky A, Monsell SE, Montine TJ, Frosch MP, Betensky RA, Hyman BT (2016) Thal amyloid stages do not significantly impact the correlation between neuropathological change and cognition in the Alzheimer disease continuum. J Neuropathol Exp Neurol 75:516\u2013526. doi: 10.1093\/jnen\/nlw026","journal-title":"J Neuropathol Exp Neurol"},{"key":"1647_CR45","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1523\/JNEUROSCI.16-10-03311.1996","volume":"16","author":"A Solodkin","year":"1996","unstructured":"Solodkin A, Veldhuizen SD, Van Hoesen GW (1996) Contingent vulnerability of entorhinal parvalbumin-containing neurons in Alzheimer\u2019s disease. J Neurosci 16:3311\u20133321","journal-title":"J Neurosci"},{"key":"1647_CR46","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","volume":"82","author":"TL Spires-Jones","year":"2014","unstructured":"Spires-Jones TL, Hyman BT (2014) The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease. Neuron 82:756\u2013771. doi: 10.1016\/j.neuron.2014.05.004","journal-title":"Neuron"},{"key":"1647_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2014.08.014","volume":"36","author":"A Stargardt","year":"2015","unstructured":"Stargardt A, Swaab DF, Bossers K (2015) The storm before the quiet: neuronal hyperactivity and Abeta in the presymptomatic stages of Alzheimer\u2019s disease. Neurobiol Aging 36:1\u201311. doi: 10.1016\/j.neurobiolaging.2014.08.014","journal-title":"Neurobiol Aging"},{"key":"1647_CR48","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.neuropsychologia.2009.03.004","volume":"47","author":"Y Stern","year":"2009","unstructured":"Stern Y (2009) Cognitive reserve. Neuropsychologia 47:2015\u20132028. doi: 10.1016\/j.neuropsychologia.2009.03.004","journal-title":"Neuropsychologia"},{"key":"1647_CR49","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1046\/j.1460-9568.1999.00652.x","volume":"11","author":"S Takahashi","year":"1999","unstructured":"Takahashi S, Ujihara H, Huang GZ, Yagyu KI, Sanbo M, Kaba H, Yagi T (1999) Reduced hippocampal LTP in mice lacking a presynaptic protein: complexin II. Eur J Neurosci 11:2359\u20132366","journal-title":"Eur J Neurosci"},{"key":"1647_CR50","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/0014-5793(95)00713-J","volume":"368","author":"S Takahashi","year":"1995","unstructured":"Takahashi S, Yamamoto H, Matsuda Z, Ogawa M, Yagyu K, Taniguchi T, Miyata T, Kaba H, Higuchi T, Okutani F (1995) Identification of two highly homologous presynaptic proteins distinctly localized at the dendritic and somatic synapses. FEBS Lett 368:455\u2013460","journal-title":"FEBS Lett"},{"key":"1647_CR51","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1523\/JNEUROSCI.3815-15.2016","volume":"36","author":"LM Tong","year":"2016","unstructured":"Tong LM, Yoon SY, Andrews-Zwilling Y, Yang A, Lin V, Lei H, Huang Y (2016) Enhancing GABA signaling during middle adulthood prevents age-dependent GABAergic interneuron decline and learning and memory deficits in ApoE4 Mice. J Neurosci 36:2316\u20132322. doi: 10.1523\/JNEUROSCI.3815-15.2016","journal-title":"J Neurosci"},{"key":"1647_CR52","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","volume":"70","author":"KA Vossel","year":"2013","unstructured":"Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, Hegde M, Cornes SB, Henry ML, Nelson AB, Seeley WW, Geschwind MD, Gorno-Tempini ML, Shih T, Kirsch HE, Garcia PA, Miller BL, Mucke L (2013) Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol 70:1158\u20131166. doi: 10.1001\/jamaneurol.2013.136","journal-title":"JAMA Neurol"},{"key":"1647_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/0006-8993(94)91709-4","volume":"667","author":"K Wakabayashi","year":"1994","unstructured":"Wakabayashi K, Honer WG, Masliah E (1994) Synapse alterations in the hippocampal-entorhinal formation in Alzheimer\u2019s disease with and without Lewy body disease. Brain Res 667:24\u201332","journal-title":"Brain Res"},{"key":"1647_CR54","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/00005072-199507000-00009","volume":"54","author":"D Wang","year":"1995","unstructured":"Wang D, Munoz DG (1995) Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer\u2019s disease and normal aged brain. J Neuropathol Exp Neurol 54:548\u2013556","journal-title":"J Neuropathol Exp Neurol"},{"key":"1647_CR55","doi-asserted-by":"publisher","first-page":"512","DOI":"10.2307\/2095465","volume":"49","author":"C Winship","year":"1984","unstructured":"Winship C, Mare RD (1984) Regression models with ordinal variables. Am Sociol Rev 49:512\u2013525","journal-title":"Am Sociol Rev"},{"key":"1647_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0306-4522(99)00104-9","volume":"93","author":"M Yamada","year":"1999","unstructured":"Yamada M, Saisu H, Ishizuka T, Takahashi H, Abe T (1999) Immunohistochemical distribution of the two isoforms of synaphin\/complexin involved in neurotransmitter release: localization at the distinct central nervous system regions and synaptic types. Neurosci 93:7\u201318","journal-title":"Neurosci"},{"key":"1647_CR57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/cercor\/8.3.261","volume":"8","author":"CE Young","year":"1998","unstructured":"Young CE, Arima K, Xie J, Hu L, Beach TG, Falkai P, Honer WG (1998) SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex 8:261\u2013268","journal-title":"Cereb Cortex"},{"key":"1647_CR58","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1037\/neu0000159","volume":"29","author":"L Yu","year":"2015","unstructured":"Yu L, Boyle PA, Segawa E, Leurgans S, Schneider JA, Wilson RS, Bennett DA (2015) Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychol 29:335\u2013343. doi: 10.1037\/neu0000159","journal-title":"Neuropsychol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-016-1647-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-016-1647-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-016-1647-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T18:14:41Z","timestamp":1718907281000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-016-1647-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,19]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["1647"],"URL":"https:\/\/doi.org\/10.1007\/s00401-016-1647-9","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,19]]},"assertion":[{"value":"10 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. W.G. Honer has received consulting fees or sat on paid advisory boards for: In Silico, Lundbeck\/Otsuka, Eli Lilly, and Roche. Dr. A.M. Barr is on the advisory board or received consulting fees from Roche Canada, and received educational grant support from BMS Canada. The Organizations cited above had no role in (and, therefore, did not influence) the design of this study, the interpretation of results, and\/or preparation of the manuscript. All other authors have no financial interest on the reported data and declare that no competing interests exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}